49
Views
123
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Association of Active Caspase 8 with the Mitochondrial Membrane during Apoptosis: Potential Roles in Cleaving BAP31 and Caspase 3 and Mediating Mitochondrion-Endoplasmic Reticulum Cross Talk in Etoposide-Induced Cell Death

, , , , &
Pages 6592-6607 | Received 29 Dec 2003, Accepted 27 Apr 2004, Published online: 27 Mar 2023
 

Abstract

It was recently demonstrated that during apoptosis, active caspase 9 and caspase 3 rapidly accumulate in the mitochondrion-enriched membrane fraction (D. Chandra and D. G. Tang, J. Biol. Chem.278:17408-17420, 2003). We now show that active caspase 8 also becomes associated with the membranes in apoptosis caused by multiple stimuli. In MDA-MB231 breast cancer cells treated with etoposide (VP16), active caspase 8 is detected only in the membrane fraction, which contains both mitochondria and endoplasmic reticulum (ER), as revealed by fractionation studies. Immunofluorescence microscopy, however, shows that procaspase 8 and active caspase 8 predominantly colocalize with the mitochondria. Biochemical analysis demonstrates that both procaspase 8 and active caspase 8 are localized mainly on the outer mitochondrial membrane (OMM) as integral proteins. Functional analyses with dominant-negative mutants, small interfering RNAs, peptide inhibitors, and Fas-associated death domain (FADD)- and caspase 8-deficient Jurkat T cells establish that the mitochondrion-localized active caspase 8 results mainly from the FADD-dependent and tumor necrosis factor receptor-associated death domain-dependent mechanisms and that caspase 8 activation plays a causal role in VP16-induced caspase 3 activation and cell death. Finally, we present evidence that the OMM-localized active caspase 8 can activate cytosolic caspase 3 and ER-localized BAP31. Cleavage of BAP31 leads to the generation of ER- localized, proapoptotic BAP20, which may mediate mitochondrion-ER cross talk through a Ca2+-dependent mechanism.

We thank M. King for providing GM701 cells; Biomide Corporation for BMD188; X. Wang for antibody against Bid; G. Shore for anti-Bap31 and -procaspase 8L antibodies, DN caspase 8, and Nex-EGFP; Y. Lazebnik for DN caspase 9; C. Vincenz for DN-FADD and DN-TRADD; and members of the Tang lab for generous support and helpful discussion. We also thank S. Bratton for insightful discussions and for critically reading the manuscript.

This work was supported in part by NIH National Cancer Institute grant CA 90297, American Cancer Society grant RSG MGO-105961, Department of Defense grant DAMD17-03-1-0137, and NIEHS Center grant ES07784. D.C. was supported by Department of Defense Postdoctoral Traineeship Award DAMD17-02-0083. B.B. is a graduate student in the GSBS program.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.